OncoSec Medical (ONCSQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ONCSQ vs. AMPE, CALA, CMRA, CLVR, EFTR, PXMD, SMFL, ATNFW, LBPSW, and AEHAWShould you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), Comera Life Sciences (CMRA), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), Smart for Life (SMFL), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), and Aesther Healthcare Acquisition (AEHAW). These companies are all part of the "pharmaceutical products" industry. OncoSec Medical vs. Ampio Pharmaceuticals Calithera Biosciences Comera Life Sciences Clever Leaves eFFECTOR Therapeutics PaxMedica Smart for Life 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ampio Pharmaceuticals (NYSE:AMPE) and OncoSec Medical (NASDAQ:ONCSQ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk. Is AMPE or ONCSQ more profitable? Company Net Margins Return on Equity Return on Assets Ampio PharmaceuticalsN/A N/A N/A OncoSec Medical N/A N/A N/A Which has preferable earnings & valuation, AMPE or ONCSQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00OncoSec MedicalN/AN/A-$34.18MN/AN/A Which has more risk & volatility, AMPE or ONCSQ? Ampio Pharmaceuticals has a beta of 3.9, suggesting that its share price is 290% more volatile than the S&P 500. Comparatively, OncoSec Medical has a beta of -19.7, suggesting that its share price is 2,070% less volatile than the S&P 500. Does the MarketBeat Community believe in AMPE or ONCSQ? Ampio Pharmaceuticals and OncoSec Medical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAmpio PharmaceuticalsOutperform VotesNo VotesUnderperform Votes78100.00% OncoSec MedicalN/AN/A Does the media favor AMPE or ONCSQ? In the previous week, Ampio Pharmaceuticals had 1 more articles in the media than OncoSec Medical. MarketBeat recorded 1 mentions for Ampio Pharmaceuticals and 0 mentions for OncoSec Medical. Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score. Company Overall Sentiment Ampio Pharmaceuticals Neutral OncoSec Medical Neutral Do institutionals & insiders believe in AMPE or ONCSQ? 5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. 3.3% of Ampio Pharmaceuticals shares are owned by insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryAmpio Pharmaceuticals beats OncoSec Medical on 5 of the 5 factors compared between the two stocks. Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart ONCSQ vs. The Competition Export to ExcelMetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1,000.00$6.52B$5.37B$8.38BDividend YieldN/A2.65%5.22%4.11%P/E RatioN/A8.9226.8419.71Price / SalesN/A253.80392.34117.39Price / CashN/A65.8538.2534.62Price / BookN/A6.466.794.50Net Income-$34.18M$143.98M$3.23B$248.18M OncoSec Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCSQOncoSec MedicalN/AN/AN/AN/A$1,000.00N/A0.0040AMPEAmpio PharmaceuticalsN/A$0.00+3.3%N/A-98.7%$4,000.00N/A0.0020Analyst ForecastGap UpCALACalithera BiosciencesN/A$0.00flatN/A-97.0%$3,000.00N/A0.0060Analyst ForecastGap UpCMRAComera Life SciencesN/AN/AN/AN/A$3,000.00$1.00M0.002CLVRClever LeavesN/A$0.00flatN/A-100.0%$1,000.00$17.42M0.00560EFTReFFECTOR TherapeuticsN/A$0.00-66.7%N/A-100.0%$1,000.00$3.55M0.0010Upcoming EarningsPXMDPaxMedicaN/A$0.00flatN/A-100.0%$1,000.00N/A0.002SMFLSmart for LifeN/A$0.00-98.9%N/A-100.0%$1,000.00$11.11M0.00110Gap DownATNFW180 Life SciencesN/A$0.01-11.0%N/A+21.5%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01+205.4%N/A-89.5%$0.00N/A0.002Gap Up Related Companies and Tools Related Companies Ampio Pharmaceuticals Alternatives Calithera Biosciences Alternatives Comera Life Sciences Alternatives Clever Leaves Alternatives eFFECTOR Therapeutics Alternatives PaxMedica Alternatives Smart for Life Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCSQ) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONCSQ Stock Free ONCSQ Stock Alerts